Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Curr Opin Support Palliat Care. 2018 Dec;12(4):489–494. doi: 10.1097/SPC.0000000000000395

Table 1.

Pharmacokinetic Properties of Benzodiazepines [2326]

Medication Onset / Peak effect Elimination Half life Dose equivalence Comments
Temazepam Onset: PO 0.5–2 h Tmax: 1.2–1.6 h 3.5–18.4 h 10 mg Slow onset Intermediate acting Low potency No active metabolites Preferred in liver disease
Diazepam Onset: IV 4–5 min Tmax: IV 1 min, IM 1 h, PO 15 min-2.5 h IV: 33–45 h PO: 44–48 h PR: 45–46 h 5 mg Fast onset Long acting Low potency Higher risk of abuse
Alprazolam Onset: PO 1 h Tmax: PO 1–2 h PO: 11–15 h 0.5 mg Intermediate onset Intermediate acting High potency Higher risk of abuse
Clonazepam Onset: PO 20–40 min Tmax: PO 1–4 h 17–60 h 0.25 mg Fast onset Long acting High potency Partial serotonin agonist
Lorazepam Onset: IV 2–3 min Tmax: PO 2 h, IM ≤3 h, SL 1 h IV: 14 h IM: 13–18 h PO: 10 h 1 mg Fast onset Short acting High potency Higher risk of abuse No active metabolites Preferred in liver disease
Midazolam Onset: IV 3–5 min, IM 15 min, PO 10–20 min Tmax: IM 0.5–1 h, PO 0.17–2.65 h 3 h 2 mg Fast onset Ultra short acting Intermediate potency Shortest half life